Goodwill and Intangible Assets

9 Months Ended

Dec. 30, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The changes in the carrying amount of goodwill by segment are as follows:



	Consumer Security			Enterprise Security			Total
	(In millions)
Net balance as of April 1, 2016	$	1,231		$	1,917		$	3,148
Acquisition of Blue Coat	—			4,086			4,086
Translation adjustments	(1		)	(6		)	(7		)
Net balance as of December 30, 2016	$	1,230		$	5,997		$	7,227

See Note 3 for more information on the Blue Coat acquisition.

Intangible assets, net



	December 30, 2016							April 1, 2016
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
	(In millions)
Customer relationships	$	1,111	$	(268	)	$	843	$	406	$	(320	)	$	86
Developed technology	883		(175		)	708		144		(84		)	60
Finite-lived trade names	19		(5		)	14		2		(2		)	—
Patents	21		(19		)	2		21		(18		)	3
Total finite-lived intangible assets	2,034		(467		)	1,567		573		(424		)	149
Indefinite-lived trade names	281		—			281		294		—			294
In-process research and development	19		—			19		—		—			—
Total intangible assets	$	2,334	$	(467	)	$	1,867	$	867	$	(424	)	$	443

As a result of our acquisition of Blue Coat, we recorded $1.6 billion of acquired intangible assets during the nine months ended December 30, 2016. See Note 3 for more information on the Blue Coat acquisition.

As of December 30, 2016, future amortization expense related to intangible assets that have finite lives is as follows by fiscal year:



	December 30, 2016
	(In millions)
Remainder of 2017	$	90
2018	352
2019	325
2020	305
2021	193
Thereafter	302
Total future amortization expense	$	1,567

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details